Citius Pharmaceuticals, Inc. (CTXR) SEC filings
CTXR SEC filings moved a median of -1.85% by the close. CTXR SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the CTXR overview →
93 measured CTXR SEC filing events.
Where these CTXR SEC filings landedvs 93 measured CTXR SEC filing reactions
| Middle 50% of CTXR SEC filing reactions | -6.32% to +3.10% |
|---|---|
| Median reaction (to close) | -1.85% |
| Measured reactions | 93 |
Point-in-time · zero look-ahead
Half of the 93 CTXR SEC filing events with a measured close landed between -6.32% and +3.10%; 34% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Citius Pharmaceuticals, For: Aug 17 | SEC filing · Form 8-K | -0.84% | -5.67% | |
| Form 10-Q Citius Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | -3.52% | -9.65% | |
| Form 8-K Citius Pharmaceuticals, For: Aug 14 | SEC filing · Form 8-K | -3.52% | -9.65% | |
| Form 8-K Citius Pharmaceuticals, For: Aug 05 | SEC filing · Form 8-K | +3.46% | +21.07% | |
| Form EFFECT Citius Pharmaceuticals, | SEC filing · Form EFFECT | -1.96% | -1.91% | |
| Form 8-K Citius Pharmaceuticals, For: Jun 01 | SEC filing · Form 8-K | -2.11% | -7.74% | |
| Form S-3 Citius Pharmaceuticals, | SEC filing · Form S-3 | -3.58% | -0.99% | |
| Form 10-Q Citius Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | -10.95% | -7.54% | |
| Form 8-K Citius Pharmaceuticals, For: May 15 | SEC filing · Form 8-K | -10.95% | -7.54% | |
| Form 8-K Citius Pharmaceuticals, For: May 04 | SEC filing · Form 8-K | -0.51% | -0.75% | |
| Form 8-K Citius Pharmaceuticals, For: Apr 23 | SEC filing · Form 8-K | +0.46% | +7.08% | |
| Form 8-K Citius Pharmaceuticals, For: Apr 23 | SEC filing · Form 8-K | -1.03% | -6.62% | |
| Form 8-K Citius Pharmaceuticals, For: Apr 06 | SEC filing · Form 8-K | -1.95% | -7.51% | |
| Form 8-K Citius Pharmaceuticals, For: Mar 31 | SEC filing · Form 8-K | -5.96% | -6.32% | |
| Form 8-K Citius Pharmaceuticals, For: Mar 10 | SEC filing · Form 8-K | +2.57% | +3.44% | |
| Form 8-K Citius Pharmaceuticals, For: Mar 04 | SEC filing · Form 8-K | -0.60% | +6.07% | |
| Form ARS Citius Pharmaceuticals, For: Sep 30 | SEC filing · Form ARS | -0.96% | +12.37% | |
| Form DEF 14A Citius Pharmaceuticals, For: Apr 06 | SEC filing · Form DEF | -0.96% | +12.37% | |
| Form DEFA14A Citius Pharmaceuticals, | SEC filing · Form DEFA14A | -0.96% | +12.37% | |
| Form 10-Q Citius Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-Q | +0.01% | -8.90% | |
| Form 8-K Citius Pharmaceuticals, For: Feb 09 | SEC filing · Form 8-K | +0.01% | -8.90% | |
| Form 10-K/A Citius Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-K | -3.55% | -3.75% | |
| Form 10-K Citius Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-K | -10.16% | -32.15% | |
| Form 8-K Citius Pharmaceuticals, For: Dec 23 | SEC filing · Form 8-K | -10.16% | -32.15% | |
| Form 8-K Citius Pharmaceuticals, For: Dec 01 | SEC filing · Form 8-K | -4.29% | -10.64% | |
| Form 8-K Citius Pharmaceuticals, For: Oct 23 | SEC filing · Form 8-K | -10.41% | -8.08% | |
| Form 8-K Citius Pharmaceuticals, For: Oct 20 | SEC filing · Form 8-K | +0.89% | -7.10% | |
| Form 10-Q Citius Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | +2.34% | +2.40% | |
| Form 8-K Citius Pharmaceuticals, For: Aug 12 | SEC filing · Form 8-K | +2.34% | +2.40% | |
| Form 8-K Citius Pharmaceuticals, For: Jul 07 | SEC filing · Form 8-K | -2.99% | -9.23% | |
| Form 8-K Citius Pharmaceuticals, For: Jun 09 | SEC filing · Form 8-K | +1.02% | -6.12% | |
| Form 8-K Citius Pharmaceuticals, For: Jun 09 | SEC filing · Form 8-K | -3.54% | +6.00% | |
| Form 8-K Citius Pharmaceuticals, For: Jun 02 | SEC filing · Form 8-K | -0.20% | -3.08% | |
| Form 8-K Citius Pharmaceuticals, For: May 29 | SEC filing · Form 8-K | -4.17% | +6.92% | |
| Form 10-Q Citius Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | -1.01% | -9.02% | |
| Form 8-K Citius Pharmaceuticals, For: May 14 | SEC filing · Form 8-K | -1.01% | -9.02% | |
| Form DEF 14A Citius Pharmaceuticals, For: Jun 09 | SEC filing · Form DEF | +0.00% | -1.86% | |
| Form DEFA14A Citius Pharmaceuticals, | SEC filing · Form DEFA14A | +0.00% | -1.86% | |
| Form 8-K Citius Pharmaceuticals, For: Apr 16 | SEC filing · Form 8-K | +0.01% | -6.62% | |
| Form PRE 14A Citius Pharmaceuticals, For: Apr 18 | SEC filing · Form PRE | +0.01% | -6.62% | |
| Form 8-K Citius Pharmaceuticals, For: Mar 28 | SEC filing · Form 8-K | +2.01% | +1.50% | |
| Form 8-K Citius Pharmaceuticals, For: Apr 01 | SEC filing · Form 8-K | -1.74% | -10.44% | |
| Form 8-K Citius Pharmaceuticals, For: Mar 10 | SEC filing · Form 8-K | +0.34% | +3.87% | |
| Form 10-Q Citius Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-Q | +0.39% | -3.14% | |
| Form 8-K Citius Pharmaceuticals, For: Feb 14 | SEC filing · Form 8-K | +0.39% | -3.14% | |
| Form 8-K Citius Pharmaceuticals, For: Feb 06 | SEC filing · Form 8-K | -1.59% | -0.75% | |
| Form 10-K/A Citius Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-K | +0.99% | -3.64% | |
| Form ARS Citius Pharmaceuticals, For: Sep 30 | SEC filing · Form ARS | +0.99% | -3.64% | |
| Form DEF 14A Citius Pharmaceuticals, For: Mar 10 | SEC filing · Form DEF | +0.99% | -3.64% | |
| Form DEFA14A Citius Pharmaceuticals, | SEC filing · Form DEFA14A | +0.99% | -3.64% | |
| Form PRE 14A Citius Pharmaceuticals, For: Jan 10 | SEC filing · Form PRE | -0.61% | +0.61% | |
| Form 8-K Citius Pharmaceuticals, For: Jan 07 | SEC filing · Form 8-K | +0.59% | -3.46% | |
| Form 8-K Citius Pharmaceuticals, For: Jan 07 | SEC filing · Form 8-K | +1.79% | +11.48% | |
| Form 10-K Citius Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-K | -1.87% | +4.27% | |
| Form 8-K Citius Pharmaceuticals, For: Dec 27 | SEC filing · Form 8-K | -1.87% | +4.27% | |
| Form 8-K Citius Pharmaceuticals, For: Dec 18 | SEC filing · Form 8-K | +0.00% | +12.36% | |
| Form 8-K Citius Pharmaceuticals, For: Nov 25 | SEC filing · Form 8-K | +0.56% | +0.00% | |
| Form 8-K Citius Pharmaceuticals, For: Nov 25 | SEC filing · Form 8-K | -17.32% | +15.92% | |
| Form 8-K Citius Pharmaceuticals, For: Nov 15 | SEC filing · Form 8-K | -3.84% | -16.25% | |
| Form 8-K Citius Pharmaceuticals, For: Nov 06 | SEC filing · Form 8-K | +2.71% | -0.18% | |
| Form 8-K Citius Pharmaceuticals, For: Nov 11 | SEC filing · Form 8-K | -0.68% | +3.12% | |
| Form 8-K Citius Pharmaceuticals, For: Sep 25 | SEC filing · Form 8-K | +1.94% | -1.84% | |
| Form 8-K Citius Pharmaceuticals, For: Sep 09 | SEC filing · Form 8-K | +1.20% | -0.59% | |
| Form 8-K Citius Pharmaceuticals, For: Sep 10 | SEC filing · Form 8-K | +0.04% | -2.36% | |
| Form 8-K Citius Pharmaceuticals, For: Sep 05 | SEC filing · Form 8-K | +1.78% | -1.85% | |
| Form 8-K Citius Pharmaceuticals, For: Aug 12 | SEC filing · Form 8-K | +3.50% | +9.89% | |
| Citius Pharmaceuticals Completes Merger of Subsidiary with TenX Keane to form Citius Oncology, Inc. | Press release | -5.55% | -6.09% | |
| Form 10-Q Citius Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | -5.55% | -6.09% | |
| Form 8-K Citius Pharmaceuticals, For: Aug 12 | SEC filing · Form 8-K | -5.55% | -6.09% | |
| Form 8-K Citius Pharmaceuticals, For: Aug 08 | SEC filing · Form 8-K | -0.57% | +1.71% | |
| Form 8-K Citius Pharmaceuticals, For: May 21 | SEC filing · Form 8-K | +0.47% | +3.10% | |
| Form 10-Q Citius Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | +0.24% | -7.45% | |
| Form 8-K Citius Pharmaceuticals, For: May 14 | SEC filing · Form 8-K | +0.24% | -7.45% | |
| Form 8-K Citius Pharmaceuticals, For: Apr 25 | SEC filing · Form 8-K | -0.55% | +0.18% | |
| Form 8-K Citius Pharmaceuticals, For: Apr 03 | SEC filing · Form 8-K | +1.42% | -2.44% | |
| Form 8-K Citius Pharmaceuticals, For: Mar 18 | SEC filing · Form 8-K | -0.38% | +0.39% | |
| Form 8-K Citius Pharmaceuticals, For: Mar 12 | SEC filing · Form 8-K | +0.53% | -3.83% | |
| Form EFFECT Citius Pharmaceuticals, | SEC filing · Form EFFECT | +1.71% | -1.10% | |
| Citius Pharmaceuticals Announces Filing of Form S-3 Shelf Registration Statement to Replace Expiring Prior Shelf Registration | Press release | +2.61% | -1.85% | |
| Form S-3 Citius Pharmaceuticals, | SEC filing · Form S-3 | +2.61% | -1.85% | |
| Form S-8 Citius Pharmaceuticals, | SEC filing · Form S-8 | +2.61% | -1.85% | |
| Form 8-K Citius Pharmaceuticals, For: Feb 14 | SEC filing · Form 8-K | -0.86% | +8.18% | |
| Form 10-Q Citius Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-Q | -0.86% | +8.18% | |
| Form 8-K Citius Pharmaceuticals, For: Feb 14 | SEC filing · Form 8-K | -0.68% | +4.31% | |
| Form ARS Citius Pharmaceuticals, For: Sep 30 | SEC filing · Form ARS | +0.29% | -1.37% | |
| Form DEF 14A Citius Pharmaceuticals, For: Mar 12 | SEC filing · Form DEF | +0.29% | -1.37% | |
| Form DEFA14A Citius Pharmaceuticals, | SEC filing · Form DEFA14A | +0.29% | -1.37% | |
| Form 8-K Citius Pharmaceuticals, For: Jan 23 | SEC filing · Form 8-K | +0.88% | -4.97% | |
| Form 8-K Citius Pharmaceuticals, For: Jan 04 | SEC filing · Form 8-K | +0.93% | +0.20% | |
| Form 8-K Citius Pharmaceuticals, For: Jan 02 | SEC filing · Form 8-K | -2.32% | -3.32% | |
| Form 10-K Citius Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-K | +2.57% | +6.41% | |
| Citius Pharmaceuticals Executes Definitive Agreement to Merge Wholly Owned Subsidiary with TenX Keane Acquisition to Form Publicly Listed Citius Oncology, Inc. | Press release | +5.71% | +28.64% | |
| Form 8-K Citius Pharmaceuticals, For: Oct 23 | SEC filing · Form 8-K | +5.71% | +28.64% |
Keep exploring
More CTXR: earnings → · analyst actions → · CTXR overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | 193 | 0.00% | 42% |
| Apollo Medical Holdings, Inc. (AMEH) | 192 | +0.16% | 55% |
| Kezar Life Sciences, Inc. (KZR) | 192 | +0.14% | 55% |
| TAKEDA PHARMA (TKPYY) | 192 | 0.00% | 47% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.